Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Details for Australian Patent Application No. 2008272832 (hide)

Owner Array BioPharma Inc. Genentech, Inc.

Inventors Xiao, Dengming; Chabot, Christine; Bencsik, Josef R.; Spencer, Keith L.; Mitchell, Ian S.; Safina, Brian S.; Xu, Rui; Kallan, Nicholas C.; Blake, James F.; Liang, Jun

Agent Pizzeys

Pub. Number AU-A-2008272832

PCT Pub. Number WO2009/006569

Priority 60/948,147 05.07.07 US

Filing date 3 July 2008

Wipo publication date 8 January 2009

International Classifications

C07D 239/70 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2009/006569 Priority application(s): WO2009/006569

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008272833-Smoking articles having reduced ignition proclivity characteristics

2008272830-Pyrimidyl cyclopentanes as AKT protein kinase inhibitors